Environmental exposure to lead and progressive diabetic nephropathy in patients with type II diabetes

Kidney International
J-L LinK-L Li

Abstract

Studies indicate that environmental exposure to lead is associated with reduced renal function. Whether lead affects progressive diabetic nephropathy is unclear. Eighty-seven patients with type II diabetes and diabetic nephropathy (serum creatinine of 1.5-3.9 mg/dl) with normal body lead burden and no lead exposure history were observed over a 12-month period. Thirty subjects with high normal body lead burdens (80-600 microg) were randomly assigned to a chelation and control group. For 3 months, the 15 chelation-group patients underwent lead-chelation therapy with calcium disodium ethylenediaminetetraacetic acid weekly until body lead burden fell <60 microg, and the 15 control group subjects received a weekly placebo. During the following 12 months, renal function was regularly assessed at 3-month intervals. The primary outcome was an elevation of serum creatinine to 1.5 times baseline value during the observation period. A secondary outcome was temporal changes in renal function following chelation therapy. Twenty-six patients achieved the primary outcome. Basal blood lead levels and body lead burden were the most important risk factors in predicting progressive diabetic nephropathy. Following chelation, the rates of decline i...Continue Reading

References

Jan 1, 1979·Archives of Internal Medicine·R P WedeenV Batuman
Jan 1, 1991·Nephron·B T Emmerson
Jan 1, 1991·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·G D NuytsM E De Broe
Jun 1, 1988·Environmental Health Perspectives·P Boscolo, M Carmignani
Jan 1, 1986·Nephron·D BehringerE Ritz
Feb 1, 1988·Kidney International·F L Van de VyverM E De Broe
Jul 7, 1983·The New England Journal of Medicine·V BatumanR P Wedeen
Feb 26, 1981·The New England Journal of Medicine·V BatumanR P Wedeen
Jun 18, 1981·The New England Journal of Medicine
Jan 1, 1980·The American Journal of Clinical Nutrition·B Isaksson
Apr 1, 1993·The American Journal of the Medical Sciences·V Batuman
Apr 17, 1996·JAMA : the Journal of the American Medical Association·R KimH Hu
Jan 1, 1996·International Archives of Occupational and Environmental Health·S H LiouP Y Chang
Sep 25, 1997·Environmental Health Perspectives·M Loghman-Adham
Feb 15, 2001·Archives of Internal Medicine·J L LinC C Yu
Dec 3, 2002·The American Journal of Medicine·Ja-Liang LinChun-Chen Yu
Jan 24, 2003·The New England Journal of Medicine·Ja-Liang LinChun-Chen Yu
Jan 24, 2003·The New England Journal of Medicine·Philip A Marsden
Mar 23, 2004·Journal of the American Society of Nephrology : JASN·Chun-Chen YuDan-Tzu Lin-Tan
Aug 4, 2004·Environmental Health Perspectives·Shirng-Wern TsaihHoward Hu

❮ Previous
Next ❯

Citations

Nov 14, 2013·Biological Trace Element Research·Giovanni ForteRoberto Madeddu
Dec 25, 2009·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Ja-Liang LinYen-Lin Huang
Oct 16, 2010·International Journal of Environmental Research and Public Health·Miguel A PadillaDavid B Allison
Aug 17, 2011·International Journal of Environmental Research and Public Health·David C Bellinger
May 22, 2013·TheScientificWorldJournal·Margaret E Sears
Jan 21, 2011·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·June T SpectorVirginia M Weaver
Mar 26, 2011·The American Journal of Medicine·Ja-Liang LinKuang-Hong Hsu
Dec 25, 2007·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Ja-Liang LinYen-Lin Huang
Jun 23, 2012·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Kuan-Hsing ChenTzung-Hai Yen
Sep 19, 2012·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Virginia M WeaverBernard G Jaar
Sep 9, 2006·Internal Medicine Journal·K M ChowC C Szeto
Oct 16, 2015·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Darcy K WeidemannJeffrey J Fadrowski
Apr 5, 2013·BioMed Research International·Wen-Hung HuangTzung-Hai Yen
Dec 2, 2014·Environmental Toxicology and Pharmacology·Sara MostafalouMohammad Abdollahi
Jun 27, 2013·Journal of Environmental Science and Health. Part A, Toxic/hazardous Substances & Environmental Engineering·Tiziana CaciariMaria Valeria Rosati
Aug 6, 2020·Journal of Clinical Medicine·Ilse J M HagedoornGozewijn D Laverman
Sep 18, 2020·Kidney International·Camilo G SotomayorStephan J L Bakker
Dec 16, 2019·Diabetes & Metabolic Syndrome·Biswapriya B Misra, Anoop Misra
Feb 20, 2021·Environmental Pollution·Bin WangYingli Lu
May 29, 2021·The American Journal of the Medical Sciences·Daniel Glicklich, William H Frishman
Nov 19, 2021·Diabetologia·Joline W J BeulensRoel C H Vermeulen
Dec 3, 2021·PloS One·Chun-Wan FangTzung-Hai Yen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
Dan-Tzu Lin-TanYen-Lin Huang
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
Kuan-Hsing ChenTzung-Hai Yen
© 2022 Meta ULC. All rights reserved